Pharma intelligence for marketing agencies

Gain insight into the pharmaceutical market landscape – we’ll help you communicate complex ideas clearly and develop customer-centric propositions.

With the pharma and healthcare sector facing increasing challenges, your clients rely more than ever on independent intelligence. As a marketer, you have to engage with multiple audiences across a variety of channels and to communicate complex information simply and persuasively.

We give you the means to identify future innovation and new market opportunities, develop customer-centric propositions, and keep a close eye on competitors. We can also help with branding, multi-channel communication and more.

What we offer

As the trusted partner of the top 50 pharmaceutical companies and 10 contract research organizations, our pharma intelligence will help you build a complete picture of the market and get access to past, current and future trends and analysis.

How it helps

You’ll get cutting-edge insights on the size and shape of markets, competitive threats, actionable customer perceptions and industry innovations.

Our accurate, reliable intelligence will help you:

Access in-depth knowledge from drug discovery to market access
Acquire a comprehensive understanding of the global pharma market
Get in-depth coverage of the entire pharmaceutical value-chain

Biomedtracker, Datamonitor Healthcare

COVID-19 24 hour webinar recordings

31 Aug 2022

Catch up on any missed COVID-19 24 hour webinar sessions

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 28 Jul 2022

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Datamonitor Healthcare

Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

By Amanda Micklus 20 Jun 2022

As more regenerative medicine products approach clinical testing and commercialization, seize this opportunity to hear detailed insights and industry best practices from preeminent sector experts. You’ll gain a deep understanding of numerous nurdles unique to bringing durable, curative therapies to patients in need.

Scrip

Get your FREE extract of the 2021 Scrip Asia 100 Report Now | Pharma Intelligence

17 Jun 2022

As we continue to navigate unprecedented times, the pharma industry in the Asia Pacific region has been persistently moving forward with clinical trial advancements.

Pink Sheet

Trumps Drug Pricing Plan: The Headlines Are The Goal - But Also A Threat

By Michael McCaughan 16 Jun 2022

The latest flurry of Executive Order activity on drug pricing reinforces the message that the President wants to own the headlines for being tough on the drug industry as Election Day looms. Looking for substance beyond that goal is a fool’s errand – but the headlines could still have significant consequences no matter who wins in November.

Datamonitor Healthcare

Global Market Access Webinar

By Louisa Joseph 16 Jun 2022

Join subject-matter experts from Datamonitor Healthcare as they use data and their industry experience to examine the challenges and opportunities brought about by recent global trends in market access. Learn how to navigate this complex terrain, as increasingly restrictive pricing and reimbursement policies are having an adverse effect on sales of launched and pipeline products across many global markets.

Pink Sheet

China-US Relationship Hinges On Changing Internal, External Forces

By Brian Yang 16 Jun 2022

Given the ongoing election challenges in the US, China has yet to officially congratulate Joe Biden as the next US president, although many world leaders are already hailing a reset in US foreign policy. Many are wondering if this and other moves indicate a quiet internal shift for China's high tech and life sciences sectors, just days after Beijing concluded a high-level plenary meeting outlining its priorities for the next five years.

Scrip

Scrip Titans of Pharma

16 Jun 2022

The 2021 Titans of Pharma provides snapshot of the industry’s top 15 leaders and the businesses they oversee, with vital statistics covering the compensation of CEOs and R&D heads, median employee pay, and company performance.

Datamonitor Healthcare, Biomedtracker, Pharmapremia

2019 Q3 Outlook Webinar

By Hardik Patel 16 Jun 2022

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.

Scrip

Webinar Recording: Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

By Ian Lloyd 15 Jun 2022

April 17, 2019, Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

Scrip, Pink Sheet

Webinar: What’s the Reality of Real World Evidence?

By Mary Jo Laffler 15 Jun 2022

The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions.

Datamonitor Healthcare

Japan Pharma Outlook Webinar Recording

By Ian Haydock 15 Jun 2022

Listen to this insightful presentation of the unique challenges and opportunities faced by Japan Pharma, hosted by the expert analysts from Pharma Intelligence.

Pharma 360

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Product

13 May 2022

Join Informa Pharma Intelligence for the “Global Oncology Opportunities” webinar!

Pink Sheet

Accelerated Approval Makes Big Splash In 2021 Novel Agents, Despite Crackdown On ‘Dangling’ Cancer Claims

By Bridget Silverman 19 Jan 2022

US FDA’s accelerated approvals hit a contemporary high in 2021, accounting for one-third of novel US approvals, but the big story was the agency’s crackdown on delinquent confirmatory trials for oncology AA indications.

Pharma intelligence for marketing agencies

Supporting market access strategy

Our unique strengths

Understand your clients’ world

Think ahead

Deliver tailored solutions

Benefit from a dedicated service

Relevant products

Below are the Product Brand List

HBW Insight: Health, Beauty and Wellness

Generics Bulletin

Pink Sheet: global policy and regulatory coverage

Pharma Intelligence latest insights

COVID-19 24 hour webinar recordings

Profitability Assessment of Branded Generic Inhalers

Immuno-Oncology Overview

Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

Get your FREE extract of the 2021 Scrip Asia 100 Report Now | Pharma Intelligence

Trumps Drug Pricing Plan: The Headlines Are The Goal - But Also A Threat

Global Market Access Webinar

China-US Relationship Hinges On Changing Internal, External Forces

Scrip Titans of Pharma

2019 Q3 Outlook Webinar

Webinar Recording: Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

Webinar: What’s the Reality of Real World Evidence?

Japan Pharma Outlook Webinar Recording

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Product

Accelerated Approval Makes Big Splash In 2021 Novel Agents, Despite Crackdown On ‘Dangling’ Cancer Claims

Next steps

This is Contactus Section

Request a live demo

Speak to Sales

Client Services

Pharma Report Store